Two subdomains of negative symptoms in psychotic disorders: Established and confirmed in two large cohorts

Albright, 2009 American Psychiatric Association, 2000 Andreasen, 1983 Andreasen, 1991, Schizophrenia: the characteristic symptoms, Schizophrenia Bulletin, 17, 27, 10.1093/schbul/17.1.27 Arbabi, 2012, A placebo-controlled study of the modafinil added to risperidone in chronic schizophrenia, Psychopharmacology, 220, 591, 10.1007/s00213-011-2513-z Bell, 1992, The positive and negative syndrome scale and the brief psychiatric rating scale. Reliability, comparability, and predictive validity, The Journal of Nervous and Mental Disease, 180, 723, 10.1097/00005053-199211000-00007 Bell, 2011, Social cognitive impairments and negative symptoms in schizophrenia: are there subtypes with distinct functional correlates?, Schizophrenia Bulletin Bell, 1994, Five-component model of schizophrenia: assessing the factorial invariance of the positive and negative syndrome scale, Psychiatry Research, 52, 295, 10.1016/0165-1781(94)90075-2 Blanchard, 2006, The structure of negative symptoms within schizophrenia: implications for assessment, Schizophrenia Bulletin, 32, 238, 10.1093/schbul/sbj013 Bobo, 2011, The effect of adjunctive armodafinil on cognitive performance and psychopathology in antipsychotic-treated patients with schizophrenia/schizoaffective disorder: a randomized, double-blind, placebo-controlled trial, Schizophrenia Research, 130, 106, 10.1016/j.schres.2011.05.015 Clarke, 2011, Are the available apathy measures reliable and valid? A review of the psychometric evidence, Journal of Psychosomatic Research, 70, 73, 10.1016/j.jpsychores.2010.01.012 Cole, 2007, The insidious effects of failing to include design-driven correlated residuals in latent-variable covariance structure analysis, Psychological Methods, 12, 381, 10.1037/1082-989X.12.4.381 Cole, 2011, Variable global dysconnectivity and individual differences in schizophrenia, Biological Psychiatry, 70, 43, 10.1016/j.biopsych.2011.02.010 Davis, 2001, The effects of olanzapine on the 5 dimensions of schizophrenia derived by factor analysis: combined results of the North American and international trials, The Journal of Clinical Psychiatry, 62, 757, 10.4088/JCP.v62n1003 Dollfus, 1995, Principal-component analyses of PANSS and SANS-SAPS in schizophrenia: their stability in an acute phase, European Psychiatry: The Journal of the Association of European Psychiatrists, 10, 97, 10.1016/0924-9338(96)80320-8 Dollfus, 1995, Stability of positive and negative symptoms in schizophrenic patients: a 3-year follow-up study, European Psychiatry: The Journal of the Association of European Psychiatrists, 10, 228, 10.1016/0924-9338(96)80299-9 Drake, 2003, The evolution of symptoms in the early course of non-affective psychosis, Schizophrenia Research, 63, 171, 10.1016/S0920-9964(02)00334-1 Emsley, 2003, The factor structure for the Positive and Negative Syndrome Scale (PANSS) in recent-onset psychosis, Schizophrenia Research, 61, 47, 10.1016/S0920-9964(02)00302-X Fitzgerald, 2003, A confirmatory factor analytic evaluation of the pentagonal PANSS model, Schizophrenia Research, 61, 97, 10.1016/S0920-9964(02)00295-5 Fitzgerald, 2002, Depressive, positive, negative and parkinsonian symptoms in schizophrenia, The Australian and New Zealand Journal of Psychiatry, 36, 340, 10.1046/j.1440-1614.2001.01004.x Fitzgerald, 2001, Subject and observer-rated quality of life in schizophrenia, Acta Psychiatrica Scandinavica, 103, 387, 10.1034/j.1600-0447.2001.00254.x Foussias, 2010, Negative symptoms in schizophrenia: avolition and Occam's razor, Schizophrenia Bulletin, 36, 359, 10.1093/schbul/sbn094 Fredrikson, 1997, PANSS symptom factors in schizophrenia, Schizophrenia Research, 24, 15, 10.1016/S0920-9964(97)82039-7 Fresan, 2005, A forced five-dimensional factor analysis and concurrent validity of the Positive and Negative Syndrome Scale in Mexican schizophrenic patients, Schizophrenia Research, 72, 123, 10.1016/j.schres.2004.03.021 Gerbing, 1984, On the meaning of within-factor correlated measurement errors, Journal of Consumer Research, 11, 572, 10.1086/208993 Grant, 2012, Randomized trial to evaluate the efficacy of cognitive therapy for low-functioning patients with schizophrenia, Archives of General Psychiatry, 69, 121, 10.1001/archgenpsychiatry.2011.129 Higashima, 1998, P300 and the thought disorder factor extracted by factor-analytic procedures in schizophrenia, Biological Psychiatry, 44, 115, 10.1016/S0006-3223(97)00359-4 Horan, 2006, Anhedonia in schizophrenia: a review of assessment strategies, Schizophrenia Bulletin, 32, 259, 10.1093/schbul/sbj009 Hu, 1998, Fit indices in covariance structure modeling: sensitivity to underparameterized model misspecification, Psychological Bulletin, 6, 424 Jöreskog, 2011 Kawasaki, 1994, Evaluation and interpretation of symptom structures in patients with schizophrenia, Acta Psychiatrica Scandinavica, 89, 399, 10.1111/j.1600-0447.1994.tb01536.x Kay, 1987, The positive and negative syndrome scale (PANSS) for schizophrenia, Schizophrenia Bulletin, 13, 231, 10.1093/schbul/13.2.261 Kay, 1990, Pyramidical model of schizophrenia, Schizophrenia Bulletin, 16, 537, 10.1093/schbul/16.3.537 Keefe, 1992, Empirical assessment of the factorial structure of clinical symptoms in schizophrenia: negative symptoms, Psychiatry Research, 44, 153, 10.1016/0165-1781(92)90049-9 Kendler, 1989, The structured interview for schizotypy (SIS): a preliminary report, Schizophrenia Bulletin, 15, 559, 10.1093/schbul/15.4.559 Kimhy, 2006, The factorial structure of the schedule for the deficit syndrome in schizophrenia, Schizophrenia Bulletin, 32, 274, 10.1093/schbul/sbi064 Kirkpatrick, 1989, The Schedule for the deficit syndrome: an instrument for research in schizophrenia, Psychiatry Research, 30, 119, 10.1016/0165-1781(89)90153-4 Kirkpatrick, 2001, A separate disease within the syndrome of schizophrenia, Archives of General Psychiatry, 58, 165, 10.1001/archpsyc.58.2.165 Kirkpatrick, 2006, The NIMH-MATRICS consensus statement on negative symptoms, Schizophrenia Bulletin, 32, 214, 10.1093/schbul/sbj053 Kirkpatrick, 2006, Subdomains within the negative symptoms of schizophrenia: commentary, Schizophrenia Bulletin, 32, 246, 10.1093/schbul/sbj054 Konings, 2006, Validity and reliability of the CAPE: a self-report instrument for the measurement of psychotic experiences in the general population, Acta Psychiatrica Scandinavica, 114, 55, 10.1111/j.1600-0447.2005.00741.x Lako, 2012, A systematic review of instruments to measure depressive symptoms in patients with schizophrenia, Journal of Affective Disorders, 140, 38, 10.1016/j.jad.2011.10.014 Lancon, 1998, Factorial structure of the Positive and Negative Syndrome Scale (PANSS): a forced five-dimensional factor analysis, Acta Psychiatrica Scandinavica, 98, 369, 10.1111/j.1600-0447.1998.tb10101.x Lancon, 1999, An exploration of the psychometric properties of the French version of the Positive and Negative Syndrome Scale, Canadian journal of psychiatry. Revue canadienne de psychiatrie, 44, 893, 10.1177/070674379904400905 Lancon, 2000, Stability of the five-factor structure of the Positive and Negative Syndrome Scale (PANSS), Schizophrenia Research, 42, 231, 10.1016/S0920-9964(99)00129-2 Lee, 2003, The five symptom dimensions and depression in schizophrenia, Psychopathology, 36, 226, 10.1159/000073447 Lei, 2005, The effect of varying degrees of nonnormality in structural equation modeling, Structural Equation Modeling, 12, 1, 10.1207/s15328007sem1201_1 Lépine, 1989, Factor analysis of the PANSS in schizophrenia Lindenmayer, 1994, Five-factor model of schizophrenia. Initial validation, The Journal of Nervous and Mental Disease, 182, 631, 10.1097/00005053-199411000-00006 Lindenmayer, 1994, A new five factor model of schizophrenia, The Psychiatric Quarterly, 65, 299, 10.1007/BF02354306 Lindenmayer, 2004, Effects of atypical antipsychotics on the syndromal profile in treatment-resistant schizophrenia, The Journal of Clinical Psychiatry, 65, 551, 10.4088/JCP.v65n0416 Lindström, 1993, Principal component analysis of the Swedish version of the Positive and Negative Syndrome Scale for schizophrenia, Nordish Journal of Psychiatry, 47, 257, 10.3109/08039489309103335 Loas, 1997, A four-dimensional model of chronic schizophrenia based on the factorial structure of the Positive and Negative Syndrome Scale (PANSS). A study of a group of 153 chronic schizophrenic patients and comparison with the factorial structure of the BPRS, L'Encephale, 23, 10 Lykouras, 2000, Five-factor model of schizophrenic psychopathology: how valid is it?, European Archives of Psychiatry and Clinical Neuroscience, 250, 93, 10.1007/s004060070041 Lyne, 2012, Can we combine symptom scales for collaborative research projects?, Journal of Psychiatric Research, 46, 233, 10.1016/j.jpsychires.2011.10.002 Marder, 1997, The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials, Journal of Clinical Psychiatry, 58, 538, 10.4088/JCP.v58n1205 Marsch, 2004, In search of golden rules: comment on hypothesis testing approaches to setting cut-off values for indices and dangers in overgeneralizing Hu and Bentler`s (1999), Structural Equation Modeling, 11, 320, 10.1207/s15328007sem1103_2 Mass, 2000, Psychopathological syndromes of schizophrenia: evaluation of the dimensional structure of the positive and negative syndrome scale, Schizophrenia Bulletin, 26, 167, 10.1093/oxfordjournals.schbul.a033437 Messinger, 2011, Avolition and expressive deficits capture negative symptom phenomenology: implications for DSM-5 and schizophrenia research, Clinical Psychology Review, 31, 161, 10.1016/j.cpr.2010.09.002 Mueser, 2004, Schizophrenia, Lancet, 363, 2063, 10.1016/S0140-6736(04)16458-1 Oorschot, 2013, Emotional experience in negative symptoms of schizophrenia–No evidence for a generalized hedonic deficit, Schizophrenia Bulletin, 39, 217, 10.1093/schbul/sbr137 Peralta, 1995, Negative symptoms in schizophrenia: a confirmatory factor analysis of competing models, The American Journal of Psychiatry, 152, 1450, 10.1176/ajp.152.10.1450 Pinkham, 2003, Implications for the neural basis of social cognition for the study of schizophrenia, The American Journal of Psychiatry, 160, 815, 10.1176/appi.ajp.160.5.815 Powel, 2001, The robustness of the likelihood ratio chi-square test for structural equation models: a meta-analysis, Journal of Educational and Behavioural Statistics, 26, 105, 10.3102/10769986026001105 Rabany, 2011, Assessment of negative symptoms and depression in schizophrenia: revision of the SANS and how it relates to the PANSS and CDSS, Schizophrenia Research, 126, 226, 10.1016/j.schres.2010.09.023 Rapado-Castro, 2010, Predominance of symptoms over time in early-onset psychosis: a principal component factor analysis of the Positive and Negative Syndrome Scale, The Journal of Clinical Psychiatry, 71, 327, 10.4088/JCP.08m04845yel Reichenberg, 2005, Stability in schizophrenia symptoms over time: findings from the Mount Sinai Pilgrim Psychiatric Center Longitudinal Study, Journal of Abnormal Psychology, 114, 363, 10.1037/0021-843X.114.3.363 Slade, 1999, Routine clinical outcome measures for patients with severe mental illness: CANSAS and HoNOS, British Journal of Psychiatry, 174, 404, 10.1192/bjp.174.5.404 Stevens, 1996 Tabachnik, 2007 Trompenaars, 2005, Tent validity, construct validity, and reliability of the WHOQOL-Bref in a population of Dutch adult psychiatric outpatients, Quality of Life Research, 14, 151, 10.1007/s11136-004-0787-x Van den Oord, 2006, Factor structure and external validity of the PANSS revisited, Schizophrenia Research, 82, 213, 10.1016/j.schres.2005.09.002 Van der Gaag, 2006, The five-factor model of the Positive and Negative Syndrome Scale I: confirmatory factor analysis fails to confirm 25 published five-factor solutions, Schizophrenia Research, 85, 273, 10.1016/j.schres.2006.04.001 Van der Gaag, 2006, The five-factor model of the Positive and Negative Syndrome Scale II: a ten-fold cross-validation of a revised model, Schizophrenia Research, 85, 280, 10.1016/j.schres.2006.03.021 Vilaplana, 2007, Validation in Spanish population of the family objective and subjective burden interview (ECFOS-II) for relatives of patients with schizophrenia, Actas Espanolas de Psiquiatria, 35, 372 Vollema, 2000, The reliability of the structured interview for schizotypy-revised, Schizophrenia Bulletin, 26, 619, 10.1093/oxfordjournals.schbul.a033482 Wechsler, 1997, WAIS-III: Wechsler adult intelligence scale White, 1997, Empirical assessment of the factorial structure of clinical symptoms in schizophrenia. A multisite, multimodel evaluation of the factorial structure of the Positive and Negative Syndrome Scale. The PANSS Study Group, Psychopathology, 30, 263, 10.1159/000285058 Wolthaus, 2000, Component structure of the positive and negative syndrome scale (PANSS) in patients with recent-onset schizophrenia and spectrum disorders, Psychopharmacology, 150, 399, 10.1007/s002130000459 Yuan, 1998, Normal theory based test statistics in structural equation modeling, British Journal of Mathematical and Statistical Psychology, 51, 289, 10.1111/j.2044-8317.1998.tb00682.x